Home > National Drug Code (NDC) > Sandostatin

Sandostatin - 0078-0183-25 - (octreotide acetate)

Alphabetical Index


Drug Information of Sandostatin

Product NDC: 0078-0183
Proprietary Name: Sandostatin
Non Proprietary Name: octreotide acetate
Active Ingredient(s): 200    ug/mL & nbsp;   octreotide acetate
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Sandostatin

Product NDC: 0078-0183
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019667
Marketing Category: NDA
Start Marketing Date: 19981021

Package Information of Sandostatin

Package NDC: 0078-0183-25
Package Description: 1 VIAL, MULTI-DOSE in 1 BOX (0078-0183-25) > 5 mL in 1 VIAL, MULTI-DOSE

NDC Information of Sandostatin

NDC Code 0078-0183-25
Proprietary Name Sandostatin
Package Description 1 VIAL, MULTI-DOSE in 1 BOX (0078-0183-25) > 5 mL in 1 VIAL, MULTI-DOSE
Product NDC 0078-0183
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name octreotide acetate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 19981021
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name OCTREOTIDE ACETATE
Strength Number 200
Strength Unit ug/mL
Pharmaceutical Classes Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]

Complete Information of Sandostatin


General Information